IκB kinase complexes: gateways to NF-κB activation and transcription

Transcription factors of the NF-κB family regulate hundreds of genes in the context of multiple important physiological and pathological processes. NF-κB activation depends on phosphorylation-induced proteolysis of inhibitory IκB molecules and NF-κB precursors by the ubiquitin-proteasome system. Most of the diverse signaling pathways that activate NF-κB converge on IκB kinases (IKK), which are essential for signal transmission. Many important details of the composition, regulation and biological function of IKK have been revealed in the last years. This review summarizes current aspects of structure and function of the regular stoichiometric components, the regulatory transient protein interactions of IKK and the mechanisms that contribute to its activation, deactivation and homeostasis. Both phosphorylation and ubiquitinatin (destructive as well as non-destructive) are crucial post-translational events in these processes. In addition to controlling induced IκB degradation in the cytoplasm and processing of the NF-κB precursor p100, nuclear IKK components have been found to act directly at the chromatin level of induced genes and to mediate responses to DNA damage. Finally, IKK is engaged in cross talk with other pathways and confers functions independently of NF-κB.

[1]  Zhijian J. Chen,et al.  The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes. , 2004, Molecular cell.

[2]  Jae-Hyuck Shim,et al.  A Novel Ubiquitin-like Domain in IκB Kinase β Is Required for Functional Activity of the Kinase* , 2004, Journal of Biological Chemistry.

[3]  G. Courtois,et al.  Two Carboxyl-terminal Activation Regions of Epstein-Barr Virus Latent Membrane Protein 1 Activate NF-κB through Distinct Signaling Pathways in Fibroblast Cell Lines* , 2003, Journal of Biological Chemistry.

[4]  M. Pierotti,et al.  The TFG protein, involved in oncogenic rearrangements, interacts with TANK and NEMO, two proteins involved in the NF‐κB pathway , 2006, Journal of cellular physiology.

[5]  L. Cantley,et al.  The Crohn's Disease Protein, NOD2, Requires RIP2 in Order to Induce Ubiquitinylation of a Novel Site on NEMO , 2004, Current Biology.

[6]  R. Brink,et al.  TRAF2 differentially regulates the canonical and noncanonical pathways of NF-kappaB activation in mature B cells. , 2004, Immunity.

[7]  A. Ciechanover,et al.  Mechanism of processing of the NF-κB2 p100 precursor: identification of the specific polyubiquitin chain-anchoring lysine residue and analysis of the role of NEDD8-modification on the SCFβ-TrCP ubiquitin ligase , 2004, Oncogene.

[8]  Yue Sun,et al.  Identification of β-Arrestin2 as a G Protein-Coupled Receptor-Stimulated Regulator of NF-κB Pathways , 2004 .

[9]  M. Emi,et al.  Differential expression of multiple isoforms of the ELKS mRNAs involved in a papillary thyroid carcinoma , 2002, Genes, chromosomes & cancer.

[10]  X. Hua,et al.  Act1, an NF-κB-activating protein , 2000 .

[11]  Shao-Cong Sun,et al.  Regulation of the Deubiquitinating Enzyme CYLD by IκB Kinase Gamma-Dependent Phosphorylation , 2005, Molecular and Cellular Biology.

[12]  M. Karin,et al.  The Carboxyl-Terminal Region of IκB Kinase γ (IKKγ) Is Required for Full IKK Activation , 2002, Molecular and Cellular Biology.

[13]  M. Karin,et al.  Activation of IKK by thymosin α1 requires the TRAF6 signalling pathway , 2005 .

[14]  D. Goeddel,et al.  Identification and Characterization of an IκB Kinase , 1997, Cell.

[15]  G. Pei,et al.  Association of β-arrestin and TRAF6 negatively regulates Toll-like receptor–interleukin 1 receptor signaling , 2006, Nature Immunology.

[16]  G. Stark,et al.  Mutant Cells That Do Not Respond to Interleukin-1 (IL-1) Reveal a Novel Role for IL-1 Receptor-Associated Kinase , 1999, Molecular and Cellular Biology.

[17]  M. Mayo,et al.  IκB Kinase α-Mediated Derepression of SMRT Potentiates Acetylation of RelA/p65 by p300 , 2006, Molecular and Cellular Biology.

[18]  Desmond J. Tobin,et al.  NF-κB transmits Eda A1/EdaR signalling to activate Shh and cyclin D1 expression, and controls post-initiation hair placode down growth , 2006, Development.

[19]  A. Ashworth,et al.  CYLD is a deubiquitinating enzyme that negatively regulates NF-κB activation by TNFR family members , 2003, Nature.

[20]  D. Goeddel,et al.  The IκB Function of NF-κB2 p100 Controls Stimulated Osteoclastogenesis , 2003, The Journal of experimental medicine.

[21]  E. Schmidt,et al.  IKKα Provides an Essential Link between RANK Signaling and Cyclin D1 Expression during Mammary Gland Development , 2001, Cell.

[22]  Bernd R. Binder,et al.  Signaling Molecules of the NF-κB Pathway Shuttle Constitutively between Cytoplasm and Nucleus* , 2002, The Journal of Biological Chemistry.

[23]  R. Gaynor,et al.  Formation of an IKKalpha-dependent transcription complex is required for estrogen receptor-mediated gene activation. , 2005, Molecular cell.

[24]  R. Gaynor,et al.  Regulation of β-Catenin Function by the IκB Kinases* , 2001, The Journal of Biological Chemistry.

[25]  Y. Matsuo,et al.  The CAP-Gly domain of CYLD associates with the proline-rich sequence in NEMO/IKKgamma. , 2004, Structure.

[26]  Ryuji Kobayashi,et al.  IκB Kinase Promotes Tumorigenesis through Inhibition of Forkhead FOXO3a , 2004, Cell.

[27]  R. Gaynor,et al.  Histone H3 phosphorylation by IKK-α is critical for cytokine-induced gene expression , 2003, Nature.

[28]  Inder M. Verma,et al.  Enhanced NF-κB activation and cellular function in macrophages lacking IκB kinase 1 (IKK1) , 2005 .

[29]  Mike Rothe,et al.  IκB Kinase-β: NF-κB Activation and Complex Formation with IκB Kinase-α and NIK , 1997 .

[30]  F. Weih,et al.  RelB is required for Peyer's patch development: differential regulation of p52–RelB by lymphotoxin and TNF , 2003, The EMBO journal.

[31]  P. Ramakrishnan,et al.  TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF-kappaB pathway by TRAF-binding TNFRs. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[32]  M. Karin How NF-κB is activated: the role of the IκB kinase (IKK) complex , 1999, Oncogene.

[33]  Zhijian J. Chen,et al.  TAB2 and TAB3 activate the NF-kappaB pathway through binding to polyubiquitin chains. , 2004, Molecular cell.

[34]  Ebrahim Zandi,et al.  Regulation of IκB Kinase (IKK) Complex by IKKγ-dependent Phosphorylation of the T-loop and C Terminus of IKKβ* , 2006, Journal of Biological Chemistry.

[35]  P. Ramakrishnan,et al.  Receptor-Specific Signaling for Both the Alternative and the Canonical NF-κB Activation Pathways by NF-κB-Inducing Kinase , 2004 .

[36]  A. Leonardi,et al.  CIKS, a connection to Ikappa B kinase and stress-activated protein kinase. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[37]  Toby Lawrence,et al.  IKKα limits macrophage NF-κB activation and contributes to the resolution of inflammation , 2005, Nature.

[38]  E. Meurs,et al.  PKR Stimulates NF-κB Irrespective of Its Kinase Function by Interacting with the IκB Kinase Complex , 2000, Molecular and Cellular Biology.

[39]  C. Scheidereit,et al.  Shared Pathways of IκB Kinase-Induced SCFβTrCP-Mediated Ubiquitination and Degradation for the NF-κB Precursor p105 and IκBα , 2001, Molecular and Cellular Biology.

[40]  G. Courtois,et al.  Complementation Cloning of NEMO, a Component of the IκB Kinase Complex Essential for NF-κB Activation , 1998, Cell.

[41]  Chi A. Ma,et al.  Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia , 2001, Nature Immunology.

[42]  G. Xiao,et al.  Induction of p100 Processing by NF-κB-inducing Kinase Involves Docking IκB Kinase α (IKKα) to p100 and IKKα-mediated Phosphorylation* , 2004, Journal of Biological Chemistry.

[43]  G. Courtois,et al.  NEMO Trimerizes through Its Coiled-coil C-terminal Domain* , 2002, The Journal of Biological Chemistry.

[44]  R. Gaynor,et al.  IKKα Regulates Estrogen-induced Cell Cycle Progression by Modulating E2F1 Expression* , 2006, Journal of Biological Chemistry.

[45]  M. Rowe,et al.  Latent Membrane Protein 1 of Epstein-Barr Virus Stimulates Processing of NF-κB2 p100 to p52* , 2003, Journal of Biological Chemistry.

[46]  C. Lim,et al.  Inhibition of nuclear factor κB activity by viral interferon regulatory factor 3 of Kaposi's sarcoma-associated herpesvirus , 2004, Oncogene.

[47]  B. Huhse,et al.  CD40 regulates the processing of NF‐κB2 p100 to p52 , 2002 .

[48]  G. Courtois,et al.  ATM Is Required for IκB Kinase (IKK) Activation in Response to DNA Double Strand Breaks* , 2000, The Journal of Biological Chemistry.

[49]  S. Ghosh,et al.  Characterization of the IκB-kinase NEMO Binding Domain* , 2002, The Journal of Biological Chemistry.

[50]  L. Neckers,et al.  Disruption of Hsp90 Function Results in Degradation of the Death Domain Kinase, Receptor-interacting Protein (RIP), and Blockage of Tumor Necrosis Factor-induced Nuclear Factor-κB Activation* , 2000, The Journal of Biological Chemistry.

[51]  A. Hoffmann,et al.  The I (cid:1) B –NF-(cid:1) B Signaling Module: Temporal Control and Selective Gene Activation , 2022 .

[52]  René Bernards,et al.  Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-κB , 2003, Nature.

[53]  Y. You,et al.  Ubiquitination of RIP Is Required for Tumor Necrosis Factor α-induced NF-κB Activation* , 2006, Journal of Biological Chemistry.

[54]  S. Srinivasula,et al.  Activation of the IκB Kinases by RIP via IKKγ/NEMO-mediated Oligomerization* , 2000, The Journal of Biological Chemistry.

[55]  S. Akira,et al.  Modulation of TLR4 Signaling by a Novel Adaptor Protein Signal-Transducing Adaptor Protein-2 in Macrophages1 , 2006, The Journal of Immunology.

[56]  J. Knop,et al.  Effects of IL‐1 receptor‐associated kinase (IRAK) expression on IL‐1 signaling are independent of its kinase activity , 1999, FEBS letters.

[57]  J. Caamaño,et al.  Regulation of secondary lymphoid organ development by the nuclear factor‐κB signal transduction pathway , 2003, Immunological reviews.

[58]  J. Caamaño,et al.  Epstein–Barr virus-encoded latent infection membrane protein 1 regulates the processing of p100 NF-κB2 to p52 via an IKKγ/NEMO-independent signalling pathway , 2003, Oncogene.

[59]  Ralf Bartenschlager,et al.  Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus , 2005, Nature.

[60]  S. Miyamoto,et al.  The Zinc Finger Domain of NEMO Is Selectively Required for NF-κB Activation by UV Radiation and Topoisomerase Inhibitors , 2002, Molecular and Cellular Biology.

[61]  David M. Rothwarf,et al.  A cytokine-responsive IκB kinase that activates the transcription factor NF-κB , 1997, Nature.

[62]  J. Dixon,et al.  Disruption of signaling by Yersinia effector YopJ, a ubiquitin-like protein protease. , 2000, Science.

[63]  E. Harhaj,et al.  Retroviral oncoprotein Tax induces processing of NF‐κB2/p100 in T cells: evidence for the involvement of IKKα , 2001 .

[64]  W. Walters,et al.  NIBP, a Novel NIK and IKKβ-binding Protein That Enhances NF-κB Activation* , 2005, Journal of Biological Chemistry.

[65]  W. Greene,et al.  Shaping the nuclear action of NF-κB , 2004, Nature Reviews Molecular Cell Biology.

[66]  W. Welch,et al.  Stress-Induced Inhibition of the NF-κB Signaling Pathway Results from the Insolubilization of the IκB Kinase Complex following Its Dissociation from Heat Shock Protein 901 , 2005, The Journal of Immunology.

[67]  Ramin Massoumi,et al.  Cyld Inhibits Tumor Cell Proliferation by Blocking Bcl-3-Dependent NF-κB Signaling , 2006, Cell.

[68]  J. Tschopp,et al.  PIDD Mediates NF-κB Activation in Response to DNA Damage , 2005, Cell.

[69]  Kyu-Jin Park,et al.  Hepatitis C Virus Nonstructural 5B Protein Regulates Tumor Necrosis Factor Alpha Signaling through Effects on Cellular IκB Kinase , 2006, Molecular and Cellular Biology.

[70]  G. Courtois,et al.  The tumour suppressor CYLD negatively regulates NF-κB signalling by deubiquitination , 2003, Nature.

[71]  A. Smahi,et al.  NEMO/IKK?: linking NF-?B to human disease , 2001 .

[72]  S. Srinivasula,et al.  Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-κB activation , 2006, Nature Cell Biology.

[73]  T. Saitoh,et al.  TWEAK Induces NF-κB2 p100 Processing and Long Lasting NF-κB Activation* , 2003, Journal of Biological Chemistry.

[74]  M. Diaz-Meco,et al.  The p62 Scaffold Regulates Nerve Growth Factor-induced NF-κB Activation by Influencing TRAF6 Polyubiquitination* , 2005, Journal of Biological Chemistry.

[75]  T. Kawabe,et al.  Helicobacter pylori Activates NF-κB via the Alternative Pathway in B Lymphocytes , 2005, The Journal of Immunology.

[76]  W. Greene,et al.  The Proto-Oncogene Cot Kinase Participates in CD3/CD28 Induction of NF-κB Acting through the NF-κB-Inducing Kinase and IκB Kinases , 1999 .

[77]  David Baltimore,et al.  Two Pathways to NF-κB , 2002 .

[78]  M. Thome CARMA1, BCL-10 and MALT1 in lymphocyte development and activation , 2004, Nature Reviews Immunology.

[79]  R. Lefkowitz,et al.  β-Arrestin inhibits NF-κB activity by means of its interaction with the NF-κB inhibitor IκBα , 2004 .

[80]  K. Jeang,et al.  Human T-lymphotropic Virus Type I Tax Activates I-κB Kinase by Inhibiting I-κB Kinase-associated Serine/Threonine Protein Phosphatase 2A* , 2003, The Journal of Biological Chemistry.

[81]  Lin-Feng Chen,et al.  NF-κB Is Essential for Induction of CYLD, the Negative Regulator of NF-κB , 2004, Journal of Biological Chemistry.

[82]  Douglas B. Evans,et al.  Mechanisms of Proinflammatory Cytokine-Induced Biphasic NF-κB Activation. , 2003 .

[83]  C. Scheidereit,et al.  The Bcl-3 oncoprotein acts as a bridging factor between NF-κB/Rel and nuclear co-regulators , 1999, Oncogene.

[84]  Zhijian J. Chen,et al.  TRAF2: A Double-Edged Sword? , 2005, Science's STKE.

[85]  A. Ryo,et al.  Regulation of NF-kappaB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA. , 2003, Molecular cell.

[86]  B. Mordmüller,et al.  Lymphotoxin and lipopolysaccharide induce NF‐κB‐p52 generation by a co‐translational mechanism , 2003, EMBO reports.

[87]  Rui Li,et al.  IκB Kinase α Regulates Subcellular Distribution and Turnover of Cyclin D1 by Phosphorylation* , 2005, Journal of Biological Chemistry.

[88]  S. Srinivasula,et al.  vCLAP, a Caspase-recruitment Domain-containing Protein of Equine Herpesvirus-2, Persistently Activates the IκB Kinases through Oligomerization of IKKγ* , 2001, The Journal of Biological Chemistry.

[89]  Gabriel Pineda,et al.  Activation of IKK by TNFalpha requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO. , 2006, Molecular cell.

[90]  L. Salmena,et al.  Requirement for Caspase-8 in NF-κB Activation by Antigen Receptor , 2005, Science.

[91]  R. Gaynor,et al.  IκB kinases: key regulators of the NF-κB pathway , 2004 .

[92]  S. Westerheide,et al.  The Putative Oncoprotein Bcl-3 Induces Cyclin D1 To Stimulate G1 Transition , 2001, Molecular and Cellular Biology.

[93]  D. Seshasayee,et al.  BAFF/BLyS receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-kappaB2. , 2002, Immunity.

[94]  Wei‐Chien Huang,et al.  Tyrosine Phosphorylation of I-κB Kinase α/β by Protein Kinase C-Dependent c-Src Activation Is Involved in TNF-α-Induced Cyclooxygenase-2 Expression1 , 2003, The Journal of Immunology.

[95]  M. Cortés,et al.  ATM and the Catalytic Subunit of DNA-Dependent Protein Kinase Activate NF-κB through a Common MEK/Extracellular Signal-Regulated Kinase/p90rsk Signaling Pathway in Response to Distinct Forms of DNA Damage , 2004, Molecular and Cellular Biology.

[96]  P. Patterson,et al.  Activation of the IκB Kinase Complex and Nuclear Factor-κB Contributes to Mutant Huntingtin Neurotoxicity , 2004, The Journal of Neuroscience.

[97]  C. Scheidereit,et al.  Requirement of Hsp90 activity for IκB kinase (IKK) biosynthesis and for constitutive and inducible IKK and NF-κB activation , 2004, Oncogene.

[98]  M. Mann,et al.  IκB Kinase (IKK)-Associated Protein 1, a Common Component of the Heterogeneous IKK Complex , 1999, Molecular and Cellular Biology.

[99]  C. Bracken,et al.  Activity of Hypoxia-inducible Factor 2α Is Regulated by Association with the NF-κB Essential Modulator* , 2005, Journal of Biological Chemistry.

[100]  S. Soond,et al.  TRUSS, a Novel Tumor Necrosis Factor Receptor 1 Scaffolding Protein That Mediates Activation of the Transcription Factor NF-κB , 2003, Molecular and Cellular Biology.

[101]  U. Siebenlist,et al.  Control of lymphocyte development by nuclear factor-κB , 2005, Nature Reviews Immunology.

[102]  S. Ghosh,et al.  PDK1 Nucleates T Cell Receptor-Induced Signaling Complex for NF-κB Activation , 2005, Science.

[103]  Jonathan D. Hron,et al.  Regulation of NF-kappaB, Th activation, and autoinflammation by the forkhead transcription factor Foxo3a. , 2004, Immunity.

[104]  Giulio Superti-Furga,et al.  A physical and functional map of the human TNF-α/NF-κB signal transduction pathway , 2004, Nature Cell Biology.

[105]  Y. Xiong,et al.  A role for NEMO/IKKγ Ubiquitination in the activation of the IκB kinase complex by TNF-α , 2003 .

[106]  Honglin Zhou,et al.  Yersinia virulence factor YopJ acts as a deubiquitinase to inhibit NF-κB activation , 2005, The Journal of experimental medicine.

[107]  T. Mak,et al.  Essential role for IκB kinase β in remodeling carma1-bcl10-malt1 complexes upon T cell activation , 2006 .

[108]  C. Scheidereit,et al.  Tetrameric Oligomerization of IκB Kinase γ (IKKγ) Is Obligatory for IKK Complex Activity and NF-κB Activation , 2003, Molecular and Cellular Biology.

[109]  S. Ley,et al.  Functions of NF-?B1 and NF-?B2 in immune cell biology , 2004 .

[110]  T. Maniatis,et al.  Site-Specific Phosphorylation of IκBα by a Novel Ubiquitination-Dependent Protein Kinase Activity , 1996, Cell.

[111]  B. Piret,et al.  The ATM protein is required for sustained activation of NF-κB following DNA damage , 1999, Oncogene.

[112]  A. Leonardi,et al.  Association of the Adaptor TANK with the IκB Kinase (IKK) Regulator NEMO Connects IKK Complexes with IKKε and TBK1 Kinases* , 2002, The Journal of Biological Chemistry.

[113]  R. Gaynor,et al.  Protein Phosphatase 2Cβ Association with the IκB Kinase Complex Is Involved in Regulating NF-κB Activity* , 2003, Journal of Biological Chemistry.

[114]  M. C. Cardoso,et al.  Inhibition of NF-kappaB by a TAT-NEMO-binding domain peptide accelerates constitutive apoptosis and abrogates LPS-delayed neutrophil apoptosis. , 2003, Blood.

[115]  E. Zandi,et al.  The IκB Kinase Complex (IKK) Contains Two Kinase Subunits, IKKα and IKKβ, Necessary for IκB Phosphorylation and NF-κB Activation , 1997, Cell.

[116]  I. Screpanti,et al.  Notch3 and pre‐TCR interaction unveils distinct NF‐κB pathways in T‐cell development and leukemia , 2006, The EMBO journal.

[117]  Zhijian J. Chen Ubiquitin signalling in the NF-κB pathway , 2005, Nature Cell Biology.

[118]  D. Goeddel,et al.  TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. , 1996, Immunity.

[119]  S. Ghosh,et al.  Selective inhibition of NF-κB activation by a peptide that blocks the interaction of NEMO with the IκB kinase complex , 2000 .

[120]  E. C. Snow,et al.  Act1, a negative regulator in CD40- and BAFF-mediated B cell survival. , 2004, Immunity.

[121]  E. Harhaj,et al.  Regulation of the NF-κB-inducing Kinase by Tumor Necrosis Factor Receptor-associated Factor 3-induced Degradation* , 2004, Journal of Biological Chemistry.

[122]  S. Akira,et al.  Essential function for the kinase TAK1 in innate and adaptive immune responses , 2005, Nature Immunology.

[123]  R. Gaynor,et al.  Heat Shock Protein 27 Association with the IκB Kinase Complex Regulates Tumor Necrosis Factor α-induced NF-κB Activation* , 2003, Journal of Biological Chemistry.

[124]  Koji Okabe,et al.  Selective inhibition of NF-κB blocks osteoclastogenesis and prevents inflammatory bone destruction in vivo , 2004, Nature Medicine.

[125]  T. Tsuruo,et al.  3-Phosphoinositide-dependent Protein Kinase-1-mediated IκB Kinase β (IKKB) Phosphorylation Activates NF-κB Signaling* , 2005, Journal of Biological Chemistry.

[126]  S. L. Wong,et al.  Towards a proteome-scale map of the human protein–protein interaction network , 2005, Nature.

[127]  C. Scheidereit,et al.  A pervasive role of ubiquitin conjugation in activation and termination of IκB kinase pathways , 2005, EMBO reports.

[128]  Christian Stehlik,et al.  PAN1/NALP2/PYPAF2, an Inducible Inflammatory Mediator That Regulates NF-κB and Caspase-1 Activation in Macrophages* , 2004, Journal of Biological Chemistry.

[129]  Zhijian J. Chen,et al.  TIFA activates IkappaB kinase (IKK) by promoting oligomerization and ubiquitination of TRAF6. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[130]  S. Gringhuis,et al.  Convergent Actions of IκB Kinase β and Protein Kinase Cδ Modulate mRNA Stability through Phosphorylation of 14-3-3β Complexed with Tristetraprolin , 2005, Molecular and Cellular Biology.

[131]  Richard B. Gaynor,et al.  Hsp27 association with the IKK complex regulates TNF-α-induced NF-κB activation , 2003 .

[132]  A. Klippel,et al.  The IκB Kinase (IKK) Complex Is Tripartite and Contains IKKγ but Not IKAP as a Regular Component* , 2000, The Journal of Biological Chemistry.

[133]  Matthew T Wheeler,et al.  The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses , 2004, Nature Immunology.

[134]  G. W. Peet,et al.  IKKα, IKKβ, and NEMO/IKKγ Are Each Required for the NF-κB-mediated Inflammatory Response Program* , 2002, The Journal of Biological Chemistry.

[135]  G. Haegeman,et al.  Recruitment of IκBα to the hes1 promoter is associated with transcriptional repression , 2004 .

[136]  S. Howell,et al.  KSHV vFLIP binds to IKK-γ to activate IKK , 2003, Journal of Cell Science.

[137]  Ki-Young Lee,et al.  TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo. , 2005, Genes & development.

[138]  K. Marcu,et al.  Gene Expression Profiling in Conjunction with Physiological Rescues of IKKα-null Cells with Wild Type or Mutant IKKα Reveals Distinct Classes of IKKα/NF-κB-dependent Genes* , 2005, Journal of Biological Chemistry.

[139]  W. Liao,et al.  The essential role of MEKK3 in TNF-induced NF-κB activation , 2001, Nature Immunology.

[140]  S. Saccani,et al.  Modulation of NF-κB Activity by Exchange of Dimers , 2003 .

[141]  Ivan Dikic,et al.  Ubiquitylation and cell signaling , 2005, The EMBO journal.

[142]  K. Guan,et al.  The Zinc Finger Mutation C417R of I-κB Kinase γ Impairs Lipopolysaccharide- and TNF-Mediated NF-κB Activation through Inhibiting Phosphorylation of the I-κB Kinase β Activation Loop1 , 2004, The Journal of Immunology.

[143]  Somasekar Seshagiri,et al.  De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling , 2004, Nature.

[144]  R. Surabhi,et al.  TAK1 is Critical for IκB Kinase-mediated Activation of the NF-κB Pathway , 2003 .

[145]  Z. Zhai,et al.  The Ret Finger Protein Inhibits Signaling Mediated by the Noncanonical and Canonical IκB Kinase Family Members1 , 2006, The Journal of Immunology.

[146]  M. Karin,et al.  The α and β Subunits of IκB Kinase (IKK) Mediate TRAF2-Dependent IKK Recruitment to Tumor Necrosis Factor (TNF) Receptor 1 in Response to TNF , 2001, Molecular and Cellular Biology.

[147]  Zhijian J. Chen,et al.  TAK1 is a ubiquitin-dependent kinase of MKK and IKK , 2001, Nature.

[148]  C. Seeger,et al.  Cardif: A protein central to innate immunity is inactivated by the HCV NS3 serine protease , 2006, Hepatology.

[149]  Jian-Dong Li,et al.  The Tumor Suppressor Cylindromatosis (CYLD) Acts as a Negative Regulator for Toll-like Receptor 2 Signaling via Negative Cross-talk with TRAF6 and TRAF7* , 2005, Journal of Biological Chemistry.

[150]  A. Leonardi,et al.  Role of the adaptor protein CIKS in the activation of the IKK complex. , 2003, Biochemical and biophysical research communications.

[151]  Jianping Ye,et al.  Serine Phosphorylation of Insulin Receptor Substrate 1 by Inhibitor κB Kinase Complex* 210 , 2002, The Journal of Biological Chemistry.

[152]  M. Karin,et al.  IκB kinase-α acts in the epidermis to control skeletal and craniofacial morphogenesis , 2004, Nature.

[153]  B. Marinari,et al.  Vav-1 and the IKKα Subunit of IκB Kinase Functionally Associate to Induce NF-κB Activation in Response to CD28 Engagement1 , 2003, The Journal of Immunology.

[154]  Zhijian J. Chen,et al.  Activation of the IκB Kinase Complex by TRAF6 Requires a Dimeric Ubiquitin-Conjugating Enzyme Complex and a Unique Polyubiquitin Chain , 2000, Cell.

[155]  R. Gaynor,et al.  Nuclear Role of IκB Kinase-γ/NF-κB Essential Modulator (IKKγ/NEMO) in NF-κB-dependent Gene Expression* , 2004, Journal of Biological Chemistry.

[156]  G Cantarella,et al.  Recruitment of the IKK signalosome to the p55 TNF receptor: RIP and A20 bind to NEMO (IKKgamma) upon receptor stimulation. , 2000, Immunity.

[157]  Robert S. Carter,et al.  Positive Regulation of IκB Kinase Signaling by Protein Serine/Threonine Phosphatase 2A* , 2005, Journal of Biological Chemistry.

[158]  Andre Levchenko,et al.  Transient IκB Kinase Activity Mediates Temporal NF-κB Dynamics in Response to a Wide Range of Tumor Necrosis Factor-α Doses* , 2006, Journal of Biological Chemistry.

[159]  M. Karin,et al.  The two NF-κB activation pathways and their role in innate and adaptive immunity , 2004 .

[160]  B. Aronow,et al.  Activation of IKKα target genes depends on recognition of specific κB binding sites by RelB:p52 dimers , 2004 .

[161]  J. Qin,et al.  Selective phosphorylations of the SRC-3/AIB1 coactivator integrate genomic reponses to multiple cellular signaling pathways. , 2004, Molecular cell.

[162]  R. Gaynor,et al.  IKKalpha regulates mitogenic signaling through transcriptional induction of cyclin D1 via Tcf. , 2003, Molecular biology of the cell.

[163]  S. Saccani,et al.  p38-dependent marking of inflammatory genes for increased NF-κB recruitment , 2002, Nature Immunology.

[164]  M. Karin,et al.  IKKα controls formation of the epidermis independently of NF-κB , 2001, Nature.

[165]  Honglin Zhou,et al.  Bcl10 activates the NF-κB pathway through ubiquitination of NEMO , 2004, Nature.

[166]  Jürgen R. Müller,et al.  Lymphotoxin β Receptor Induces Sequential Activation of Distinct NF-κB Factors via Separate Signaling Pathways* , 2003, The Journal of Biological Chemistry.

[167]  Y. Xiong,et al.  A Role for NF-κB Essential Modifier/IκB Kinase-γ (NEMO/IKKγ) Ubiquitination in the Activation of the IκB Kinase Complex by Tumor Necrosis Factor-α* , 2003, Journal of Biological Chemistry.

[168]  E. Zandi,et al.  Complete reconstitution of human IkappaB kinase (IKK) complex in yeast. Assessment of its stoichiometry and the role of IKKgamma on the complex activity in the absence of stimulation. , 2001, The Journal of biological chemistry.

[169]  D. Hohl,et al.  The Tumor Suppressor CYLD Interacts with TRIP and Regulates Negatively Nuclear Factor κB Activation by Tumor Necrosis Factor , 2003, The Journal of experimental medicine.

[170]  P. Krammer,et al.  Activation or suppression of NFκB by HPK1 determines sensitivity to activation‐induced cell death , 2005 .

[171]  K. Nakayama,et al.  Common Pathway for the Ubiquitination of IκBα, IκBβ, and IκBε Mediated by the F-Box Protein FWD1* , 1999, The Journal of Biological Chemistry.

[172]  K. Jeang,et al.  An Alternative Splice Product of IκB Kinase (IKKγ), IKKγ-Δ, DifferentiallyMediates Cytokine and Human T-Cell Leukemia Virus Type 1 Tax-Induced NF-κB Activation , 2006, Journal of Virology.

[173]  C. Shi,et al.  Tumor Necrosis Factor (TNF)-induced Germinal Center Kinase-related (GCKR) and Stress-activated Protein Kinase (SAPK) Activation Depends upon the E2/E3 Complex Ubc13-Uev1A/TNF Receptor-associated Factor 2 (TRAF2)* , 2003, The Journal of Biological Chemistry.

[174]  Z. Zhai,et al.  CSN3 interacts with IKKγ and inhibits TNF‐ but not IL‐1‐induced NF‐κB activation , 2001 .

[175]  Sankar Ghosh,et al.  Signaling to NF-kappaB. , 2004, Genes & development.

[176]  G. Courtois,et al.  The Trimerization Domain of Nemo Is Composed of the Interacting C-terminal CC2 and LZ Coiled-coil Subdomains* , 2004, Journal of Biological Chemistry.

[177]  J. Christman,et al.  Expression by Direct Interaction with I B Activation and Cyclooxygenase-2 Κ Nf- Hepatitis C Virus Core Protein Suppresses , 2004 .

[178]  D. Green,et al.  The Lymphotoxin-β Receptor Induces Different Patterns of Gene Expression via Two NF-κB Pathways , 2002 .

[179]  E. Kieff,et al.  IκB kinase β phosphorylates Dok1 serines in response to TNF, IL-1, or γ radiation , 2004 .

[180]  A. Manning,et al.  Fanconi anemia protein complex is a novel target of the IKK signalsome , 2002, Journal of cellular biochemistry.

[181]  Lu Zhang,et al.  Hsp70 promotes TNF-mediated apoptosis by binding IKKγ and impairing NF-κB survival signaling , 2004 .

[182]  P. Chaudhary,et al.  Activation of alternative NF-κB pathway by human herpes virus 8-encoded Fas-associated death domain-like IL-1β-converting enzyme inhibitory protein (vFLIP) , 2004 .

[183]  A. Leonardi,et al.  Physical and Functional Interaction of CARMA1 and CARMA3 with Iκ Kinase γ-NFκB Essential Modulator* , 2004, Journal of Biological Chemistry.

[184]  D. Goeddel,et al.  TNF-induced recruitment and activation of the IKK complex require Cdc37 and Hsp90. , 2002, Molecular cell.

[185]  S. Saccani,et al.  Degradation of Promoter-bound p65/RelA Is Essential for the Prompt Termination of the Nuclear Factor κB Response , 2004, The Journal of experimental medicine.

[186]  E. Harhaj,et al.  NF-κB-Inducing Kinase Regulates the Processing of NF-κB2 p100 , 2001 .

[187]  J. Qin,et al.  Regulation of SRC-3 (pCIP/ACTR/AIB-1/RAC-3/TRAM-1) Coactivator Activity by IκB Kinase , 2002, Molecular and Cellular Biology.

[188]  A. Ashworth,et al.  Identification of the familial cylindromatosis tumour-suppressor gene , 2000, Nature Genetics.

[189]  A. Baldwin,et al.  IκB Kinase α and p65/RelA Contribute to Optimal Epidermal Growth Factor-induced c-fos Gene Expression Independent of IκBα Degradation* , 2004, Journal of Biological Chemistry.

[190]  R. Hay,et al.  SUMO: a history of modification. , 2005, Molecular cell.

[191]  C. Cheng‐Mayer,et al.  Molecular Mechanism of hTid-1, the Human Homolog of Drosophila Tumor Suppressor l(2)Tid, in the Regulation of NF-κB Activity and Suppression of Tumor Growth , 2005, Molecular and Cellular Biology.

[192]  H. Nakano,et al.  The death domain kinase RIP has an essential role in DNA damage-induced NF-kappa B activation. , 2003, Genes & development.

[193]  Matthias Mann,et al.  IKK-1 and IKK-2: Cytokine-Activated IκB Kinases Essential for NF-κB Activation , 1997 .

[194]  T. Maniatis,et al.  NF-(cid:1) B signaling pathways in mammalian and insect innate immunity , 2001 .

[195]  Shao-Cong Sun,et al.  Negative Regulation of JNK Signaling by the Tumor Suppressor CYLD* , 2004, Journal of Biological Chemistry.

[196]  Concepción Rodríguez-Esteban,et al.  Zebrafish IκB Kinase 1 Negatively Regulates NF-κB Activity , 2005, Current Biology.

[197]  Christopher K. Glass,et al.  Exchange of N-CoR Corepressor and Tip60 Coactivator Complexes Links Gene Expression by NF-κB and β-Amyloid Precursor Protein , 2002, Cell.

[198]  S. Miyamoto,et al.  Sequential Modification of NEMO/IKKγ by SUMO-1 and Ubiquitin Mediates NF-κB Activation by Genotoxic Stress , 2003, Cell.

[199]  Hong-shan Wang,et al.  BAFF-induced NEMO-independent processing of NF-κB2 in maturing B cells , 2002, Nature Immunology.

[200]  Michael Karin,et al.  Activation by IKKα of a Second, Evolutionary Conserved, NF-κB Signaling Pathway , 2001, Science.

[201]  R. Tibbetts,et al.  Molecular Linkage Between the Kinase ATM and NF-κB Signaling in Response to Genotoxic Stimuli , 2006, Science.

[202]  Shao-Cong Sun,et al.  Regulation of T cell development by the deubiquitinating enzyme CYLD , 2006, Nature Immunology.

[203]  K. N. Pennington,et al.  In Vivo Identification of Inducible Phosphoacceptors in the IKKγ/NEMO Subunit of Human IκB Kinase* , 2003, Journal of Biological Chemistry.

[204]  M. Karin,et al.  Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. , 2000, Annual review of immunology.